Atlas Trials

Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index

Clinical trial NCT06706050 · COMPLETED

Trial details

NCT number
NCT06706050
Sponsor
Ho-Yeon Song
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Xerosis
Start date
2023-05-08
Primary completion
2023-06-16
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.